60 Degrees Pharmaceuticals (Nasdaq: SXTP) is a growth-oriented biotechnology company with a goal of using cutting-edge biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases. 60P has successfully achieved regulatory approval of ARAKODA® (tafenoquine), a malaria preventative treatment that has been on the market since late 2019. Currently, 60P’s pipeline includes development programs for Tafenoquine and Celgosivir targeting fungal, tick-borne, and other viral diseases.
Sixty Degrees is a client of RedChip. Visit RedChip.com to learn more.
Sixty Degrees is a client of RedChip. Visit RedChip.com to learn more.
Ajouter un commentaire
Up Next
Autoplay
-
56:48
Investor webinar: your questions answered | Scottish Mortgage | March 2024
-
20:24
Severe Weather and Flooding: DEMS Webinar (March 2025)
-
1:50:33
Comrades Marathon Webinar - 5 March 2025
-
00:46
Enlivex (Nasdaq: ENLV) Investor Webinar Replay on Promising Allocetra™ Osteoarthritis Data!
-
1:01:45
February 2025 Investor Webinar
-
1:30:45
ML ACADÉMIE FORMATION E-COMMERCE EN LIGNE, ENTREPRENDRE, GESTION PAGE, FRELENCE & COACHING WEBINAIRE
-
01:06
DESACTIVER Facebook RENCONTRE, comment mettre en pause son profil ou un compte Facebook Dating
-
13:35
Tuto Complet #3 - Les Projections D'Hosoda (Avec Ichimoku)
-
18:53
Un Business Ultra Rentable à Lancer en Afrique : Gagne 1 750 000 FCFA Par Mois
-
04:35
Guadagna con l'affiliazione Agrieuro
Chargement...
Commentaires